Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

NCT06980623 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

26000

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Heart Failure

Interventions

DRUG: Tirzepatide
DRUG: Semaglutide

Sponsor

Brigham and Women's Hospital